These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


321 related items for PubMed ID: 32016611

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Gold nanostar-polymer hybrids for siRNA delivery: Polymer design towards colloidal stability and in vitro studies on breast cancer cells.
    Sardo C, Bassi B, Craparo EF, Scialabba C, Cabrini E, Dacarro G, D'Agostino A, Taglietti A, Giammona G, Pallavicini P, Cavallaro G.
    Int J Pharm; 2017 Mar 15; 519(1-2):113-124. PubMed ID: 28093325
    [Abstract] [Full Text] [Related]

  • 23. Novel biotinylated chitosan-graft-polyethyleneimine copolymer as a targeted non-viral vector for anti-EGF receptor siRNA delivery in cancer cells.
    Darvishi MH, Nomani A, Amini M, Shokrgozar MA, Dinarvand R.
    Int J Pharm; 2013 Nov 18; 456(2):408-16. PubMed ID: 24012865
    [Abstract] [Full Text] [Related]

  • 24. Cholesterol grafted cationic lipopolymers: Potential siRNA carriers for selective chronic myeloid leukemia therapy.
    Remant KC, Thapa B, Valencia-Serna J, Domun SS, Dimitroff C, Jiang X, Uludağ H.
    J Biomed Mater Res A; 2020 Mar 18; 108(3):565-580. PubMed ID: 31714657
    [Abstract] [Full Text] [Related]

  • 25. Effective response of doxorubicin-sensitive and -resistant breast cancer cells to combinational siRNA therapy.
    Aliabadi HM, Maranchuk R, Kucharski C, Mahdipoor P, Hugh J, Uludağ H.
    J Control Release; 2013 Nov 28; 172(1):219-228. PubMed ID: 23994345
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Impact of lipid substitution on assembly and delivery of siRNA by cationic polymers.
    Aliabadi HM, Landry B, Bahadur RK, Neamnark A, Suwantong O, Uludağ H.
    Macromol Biosci; 2011 May 12; 11(5):662-72. PubMed ID: 21322108
    [Abstract] [Full Text] [Related]

  • 28. Effective down-regulation of breast cancer resistance protein (BCRP) by siRNA delivery using lipid-substituted aliphatic polymers.
    Aliabadi HM, Landry B, Mahdipoor P, Hsu CY, Uludağ H.
    Eur J Pharm Biopharm; 2012 May 12; 81(1):33-42. PubMed ID: 22311298
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Suppression of tumor growth in lung cancer xenograft model mice by poly(sorbitol-co-PEI)-mediated delivery of osteopontin siRNA.
    Cho WY, Hong SH, Singh B, Islam MA, Lee S, Lee AY, Gankhuyag N, Kim JE, Yu KN, Kim KH, Park YC, Cho CS, Cho MH.
    Eur J Pharm Biopharm; 2015 Aug 12; 94():450-62. PubMed ID: 26141346
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A novel tyrosine-modified low molecular weight polyethylenimine (P10Y) for efficient siRNA delivery in vitro and in vivo.
    Ewe A, Przybylski S, Burkhardt J, Janke A, Appelhans D, Aigner A.
    J Control Release; 2016 May 28; 230():13-25. PubMed ID: 27061141
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate.
    Park K, Lee MY, Kim KS, Hahn SK.
    Biomaterials; 2010 Jul 28; 31(19):5258-65. PubMed ID: 20378167
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.